Kingdon Capital Management’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-66,665
| Closed | -$2.2K | – | 88 |
|
|
2023
Q1 | $2.2K | Hold |
66,665
| – | – | ﹤0.01% | 45 |
|
|
2022
Q4 | $3.54K | Hold |
66,665
| – | – | ﹤0.01% | 38 |
|
|
2022
Q3 | $2K | Hold |
66,665
| – | – | ﹤0.01% | 46 |
|
|
2022
Q2 | $2K | Hold |
66,665
| – | – | ﹤0.01% | 56 |
|
|
2022
Q1 | $11K | Hold |
66,665
| – | – | ﹤0.01% | 66 |
|
|
2021
Q4 | $36K | Hold |
66,665
| – | – | ﹤0.01% | 61 |
|
|
2021
Q3 | $48K | Hold |
66,665
| – | – | 0.01% | 53 |
|
|
2021
Q2 | $69K | Buy |
+66,665
| New | +$69K | 0.01% | 58 |
|